The New York Mets' difficult start to the season has just gotten more complicated. Already sitting at the bottom of the NL East with a 7-12 record, the team is now facing a new and concerning injury to a key offseason acquisition.

Infielder Jorge Polanco, who was already sidelined with an Achilles/ankle issue, is now dealing with a separate problem: right wrist soreness. According to reports, he is awaiting MRI results, casting significant doubt on his immediate future in the lineup.

This development is a major blow for a player the Mets were counting on to solidify their infield. Polanco's $40 million contract came with expectations of offensive production, but he has struggled mightily so far, posting a .179 batting average and a .532 OPS. His -0.3 bWAR is a clear indicator of his early-season woes, which have contributed to the team's sluggish performance.

Just as his ankle was reportedly improving, this new wrist ailment threatens to derail any chance of a quick turnaround. For a Mets team desperate for stability and a spark, losing another starting infielder—especially one with his potential—is the last thing they need. The club and its fans will be anxiously awaiting the MRI results, hoping this is a minor setback rather than a long-term issue that sidelines another expensive piece of their puzzle.